44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts
Identifieur interne : 000154 ( Istex/Checkpoint ); précédent : 000153; suivant : 00015544th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts
Auteurs :Source :
- Pediatric Blood & Cancer [ 1545-5009 ] ; 2012-12-01.
English descriptors
- Teeft :
- 2department, 2paediatric, 2pediatric, 2pediatric oncology, 2pediatrics, 3department, 3pediatric, 4department, 4pediatric, 5department, 5pediatric, 6department, Abnormality, Acute lymphoblastic leukaemia, Acute lymphoblastic leukemia, Adjuvant, Adrenocortical, Adult survivors, Aire, Alder, Allele, Allogeneic, Anaplastic, Anderson cancer center, Anthracycline, Apoptosis, Argentina, Assay, Asymptomatic, Autologous, Baseline, Biomarkers, Biostatistics, Bone marrow, Brain tumors, Buenos, Buenos aires, Canada purpose, Cancer, Cancer patients, Cancer research, Cancer treatment, Carboplatin, Carcinoma, Cardiac, Carlos, Cell lines, Centre, Chemotherapy, Child health, Childhood cancer, Childhood cancer survivors, Childrens, Chromosome, Cisplatin, Clinical trials, Clinician, Cohort, Complete remission, Control group, Cranial, Craniospinal, Cristina, Cyclophosphamide, Cytarabine, Cytometry, Cytotoxic, Database, December, Deletion, Diagnosis, Dkfz, Dos, Doxorubicin, Dysfunction, Egfr, Embryonal, Enucleation, Ependymoma, Ependymomas, Epidemiology, Essen, Etoposide, Evaluable, Ewing, Ewing sarcoma, Excision, Fossa, Foundation trust, Gcts, Gene expression, Genetics, Genome, Genomic, Genotype, Germany purpose, Glioma, Great ormond street hospital, Groningen, Guideline, Gvhd, Haematology, Healthcare, Heidelberg, Hematological, Hematology, Hematopoietic, Hepatic, Hepatoblastoma, Heterogeneity, High risk, Histological, Histology, Histopathology, Hodgkin lymphoma, Hsct, Hypoxia, Imaging, Immunohistochemistry, Immunology, Immunotherapy, India institute, India purpose, Inhibitor, Institut curie, Instituto, Intracranial, Intrathecal, Invasive, Irccs, Istituto, Italy purpose, January, Jude research hospital, Karolinska, Kiel, Kinase, Kumar, Late effects, Leukaemia, Leukemia, Leuven, Liposomal, Lymphoblastic, Lymphoblastic leukemia, Lymphoma, Malformation, Malignancy, Malignant, Marta, Median, Median time, Medical records, Medical sciences, Medical university, Medulloblastoma, Medulloblastomas, Melanoma, Metastasis, Metastatic, Metastatic disease, Methotrexate, Methylation, Mgcts, Milano, Mirnas, Morbidity, Mrna, Mucositis, Muenster, Multidisciplinary, Multivariate, Multivariate analysis, Mumbai, Munster, Mutation, Mycn, Nacional, Nancial, Nazionale, Ndings, Neoadjuvant, Neoadjuvant chemotherapy, Neoplasm, Nephrectomy, Nephroblastoma, Netherlands, Netherlands purpose, Neuroblastoma, Neurocognitive, Neurosurgery, Neutropenia, Nijmegen, Node, Nodule, October, Older children, Oncologist, Oncology, Ongoing, Optic, Organisation, Ormond, Osteonecrosis, Osteosarcoma, Ovarian, Overall survival, Padova, Paediatric, Paediatric oncology, Paediatrics, Palliative care, Pathway, Paulo, Pediatr, Pediatr blood cancer, Pediatric, Pediatric hematology, Pediatric oncology, Pediatric patients, Pediatric surgery, Pediatrica, Pediatrics, Phenotype, Pnet, Polymorphism, Postoperative, Precursor, Predictor, Prednisolone, Preliminary results, Preoperative, Preoperative chemotherapy, Preto, Prognosis, Prognostic, Prognostic factors, Progression, Progressive disease, Prospective study, Protocol, Provider, Psychosocial, Radiation oncology, Radiation therapy, Radiological, Radiology, Radiotherapy, Randomised, Randomized, Range years, Rearrangement, Receptor, Recurrence, Regimen, Relapse, Remission, Renal, Resected, Resection, Retinoblastoma, Retrospective, Retrospective analysis, Retrospectively, Rhabdoid, Rhabdomyosarcoma, Ribeirao, Ribeirao preto, Risk factors, Rotterdam, Roussy, Royal marsden hospital, Sarcoma, Sequencing, Sibling, Sick children, Siop, Siop abstracts, States purpose, Stefan, Stockholm, Subgroup, Surgery, Surgical, Surgical resection, Survival rate, Survivor, Syndrome, Systematic review, Tata, Tata memorial hospital, Temozolomide, Teratoma, Therapy, Toxicity, Transplantation, Treatment outcome, Tumor, Tumor growth, Tumori, Tumour, Univariate, Univariate analysis, University hospital, Vegf, Venous, Villejuif, Vincristine, Whilst, Wilms, Wilms tumor, Wroclaw, Xenograft, Young adults, Young children, Young people.
Url:
DOI: 10.1002/pbc.24295
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:3672584BC4E06AB98E4CE39A8536380086DA16DALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3672584BC4E06AB98E4CE39A8536380086DA16DA</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1002/pbc.24295</idno>
<idno type="url">https://api.istex.fr/document/3672584BC4E06AB98E4CE39A8536380086DA16DA/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000562</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000562</idno>
<idno type="wicri:Area/Istex/Curation">000531</idno>
<idno type="wicri:Area/Istex/Checkpoint">000154</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000154</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts</title>
</analytic>
<monogr></monogr>
<series><title level="j">Pediatric Blood & Cancer</title>
<title level="j" type="abbrev">Pediatr. Blood Cancer</title>
<idno type="ISSN">1545-5009</idno>
<idno type="eISSN">1545-5017</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2012-12-01">2012-12-01</date>
<biblScope unit="volume">59</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="965">965</biblScope>
<biblScope unit="page" to="1152">1152</biblScope>
</imprint>
<idno type="ISSN">1545-5009</idno>
</series>
<idno type="istex">3672584BC4E06AB98E4CE39A8536380086DA16DA</idno>
<idno type="DOI">10.1002/pbc.24295</idno>
<idno type="ArticleID">PBC24295</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1545-5009</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>2department</term>
<term>2paediatric</term>
<term>2pediatric</term>
<term>2pediatric oncology</term>
<term>2pediatrics</term>
<term>3department</term>
<term>3pediatric</term>
<term>4department</term>
<term>4pediatric</term>
<term>5department</term>
<term>5pediatric</term>
<term>6department</term>
<term>Abnormality</term>
<term>Acute lymphoblastic leukaemia</term>
<term>Acute lymphoblastic leukemia</term>
<term>Adjuvant</term>
<term>Adrenocortical</term>
<term>Adult survivors</term>
<term>Aire</term>
<term>Alder</term>
<term>Allele</term>
<term>Allogeneic</term>
<term>Anaplastic</term>
<term>Anderson cancer center</term>
<term>Anthracycline</term>
<term>Apoptosis</term>
<term>Argentina</term>
<term>Assay</term>
<term>Asymptomatic</term>
<term>Autologous</term>
<term>Baseline</term>
<term>Biomarkers</term>
<term>Biostatistics</term>
<term>Bone marrow</term>
<term>Brain tumors</term>
<term>Buenos</term>
<term>Buenos aires</term>
<term>Canada purpose</term>
<term>Cancer</term>
<term>Cancer patients</term>
<term>Cancer research</term>
<term>Cancer treatment</term>
<term>Carboplatin</term>
<term>Carcinoma</term>
<term>Cardiac</term>
<term>Carlos</term>
<term>Cell lines</term>
<term>Centre</term>
<term>Chemotherapy</term>
<term>Child health</term>
<term>Childhood cancer</term>
<term>Childhood cancer survivors</term>
<term>Childrens</term>
<term>Chromosome</term>
<term>Cisplatin</term>
<term>Clinical trials</term>
<term>Clinician</term>
<term>Cohort</term>
<term>Complete remission</term>
<term>Control group</term>
<term>Cranial</term>
<term>Craniospinal</term>
<term>Cristina</term>
<term>Cyclophosphamide</term>
<term>Cytarabine</term>
<term>Cytometry</term>
<term>Cytotoxic</term>
<term>Database</term>
<term>December</term>
<term>Deletion</term>
<term>Diagnosis</term>
<term>Dkfz</term>
<term>Dos</term>
<term>Doxorubicin</term>
<term>Dysfunction</term>
<term>Egfr</term>
<term>Embryonal</term>
<term>Enucleation</term>
<term>Ependymoma</term>
<term>Ependymomas</term>
<term>Epidemiology</term>
<term>Essen</term>
<term>Etoposide</term>
<term>Evaluable</term>
<term>Ewing</term>
<term>Ewing sarcoma</term>
<term>Excision</term>
<term>Fossa</term>
<term>Foundation trust</term>
<term>Gcts</term>
<term>Gene expression</term>
<term>Genetics</term>
<term>Genome</term>
<term>Genomic</term>
<term>Genotype</term>
<term>Germany purpose</term>
<term>Glioma</term>
<term>Great ormond street hospital</term>
<term>Groningen</term>
<term>Guideline</term>
<term>Gvhd</term>
<term>Haematology</term>
<term>Healthcare</term>
<term>Heidelberg</term>
<term>Hematological</term>
<term>Hematology</term>
<term>Hematopoietic</term>
<term>Hepatic</term>
<term>Hepatoblastoma</term>
<term>Heterogeneity</term>
<term>High risk</term>
<term>Histological</term>
<term>Histology</term>
<term>Histopathology</term>
<term>Hodgkin lymphoma</term>
<term>Hsct</term>
<term>Hypoxia</term>
<term>Imaging</term>
<term>Immunohistochemistry</term>
<term>Immunology</term>
<term>Immunotherapy</term>
<term>India institute</term>
<term>India purpose</term>
<term>Inhibitor</term>
<term>Institut curie</term>
<term>Instituto</term>
<term>Intracranial</term>
<term>Intrathecal</term>
<term>Invasive</term>
<term>Irccs</term>
<term>Istituto</term>
<term>Italy purpose</term>
<term>January</term>
<term>Jude research hospital</term>
<term>Karolinska</term>
<term>Kiel</term>
<term>Kinase</term>
<term>Kumar</term>
<term>Late effects</term>
<term>Leukaemia</term>
<term>Leukemia</term>
<term>Leuven</term>
<term>Liposomal</term>
<term>Lymphoblastic</term>
<term>Lymphoblastic leukemia</term>
<term>Lymphoma</term>
<term>Malformation</term>
<term>Malignancy</term>
<term>Malignant</term>
<term>Marta</term>
<term>Median</term>
<term>Median time</term>
<term>Medical records</term>
<term>Medical sciences</term>
<term>Medical university</term>
<term>Medulloblastoma</term>
<term>Medulloblastomas</term>
<term>Melanoma</term>
<term>Metastasis</term>
<term>Metastatic</term>
<term>Metastatic disease</term>
<term>Methotrexate</term>
<term>Methylation</term>
<term>Mgcts</term>
<term>Milano</term>
<term>Mirnas</term>
<term>Morbidity</term>
<term>Mrna</term>
<term>Mucositis</term>
<term>Muenster</term>
<term>Multidisciplinary</term>
<term>Multivariate</term>
<term>Multivariate analysis</term>
<term>Mumbai</term>
<term>Munster</term>
<term>Mutation</term>
<term>Mycn</term>
<term>Nacional</term>
<term>Nancial</term>
<term>Nazionale</term>
<term>Ndings</term>
<term>Neoadjuvant</term>
<term>Neoadjuvant chemotherapy</term>
<term>Neoplasm</term>
<term>Nephrectomy</term>
<term>Nephroblastoma</term>
<term>Netherlands</term>
<term>Netherlands purpose</term>
<term>Neuroblastoma</term>
<term>Neurocognitive</term>
<term>Neurosurgery</term>
<term>Neutropenia</term>
<term>Nijmegen</term>
<term>Node</term>
<term>Nodule</term>
<term>October</term>
<term>Older children</term>
<term>Oncologist</term>
<term>Oncology</term>
<term>Ongoing</term>
<term>Optic</term>
<term>Organisation</term>
<term>Ormond</term>
<term>Osteonecrosis</term>
<term>Osteosarcoma</term>
<term>Ovarian</term>
<term>Overall survival</term>
<term>Padova</term>
<term>Paediatric</term>
<term>Paediatric oncology</term>
<term>Paediatrics</term>
<term>Palliative care</term>
<term>Pathway</term>
<term>Paulo</term>
<term>Pediatr</term>
<term>Pediatr blood cancer</term>
<term>Pediatric</term>
<term>Pediatric hematology</term>
<term>Pediatric oncology</term>
<term>Pediatric patients</term>
<term>Pediatric surgery</term>
<term>Pediatrica</term>
<term>Pediatrics</term>
<term>Phenotype</term>
<term>Pnet</term>
<term>Polymorphism</term>
<term>Postoperative</term>
<term>Precursor</term>
<term>Predictor</term>
<term>Prednisolone</term>
<term>Preliminary results</term>
<term>Preoperative</term>
<term>Preoperative chemotherapy</term>
<term>Preto</term>
<term>Prognosis</term>
<term>Prognostic</term>
<term>Prognostic factors</term>
<term>Progression</term>
<term>Progressive disease</term>
<term>Prospective study</term>
<term>Protocol</term>
<term>Provider</term>
<term>Psychosocial</term>
<term>Radiation oncology</term>
<term>Radiation therapy</term>
<term>Radiological</term>
<term>Radiology</term>
<term>Radiotherapy</term>
<term>Randomised</term>
<term>Randomized</term>
<term>Range years</term>
<term>Rearrangement</term>
<term>Receptor</term>
<term>Recurrence</term>
<term>Regimen</term>
<term>Relapse</term>
<term>Remission</term>
<term>Renal</term>
<term>Resected</term>
<term>Resection</term>
<term>Retinoblastoma</term>
<term>Retrospective</term>
<term>Retrospective analysis</term>
<term>Retrospectively</term>
<term>Rhabdoid</term>
<term>Rhabdomyosarcoma</term>
<term>Ribeirao</term>
<term>Ribeirao preto</term>
<term>Risk factors</term>
<term>Rotterdam</term>
<term>Roussy</term>
<term>Royal marsden hospital</term>
<term>Sarcoma</term>
<term>Sequencing</term>
<term>Sibling</term>
<term>Sick children</term>
<term>Siop</term>
<term>Siop abstracts</term>
<term>States purpose</term>
<term>Stefan</term>
<term>Stockholm</term>
<term>Subgroup</term>
<term>Surgery</term>
<term>Surgical</term>
<term>Surgical resection</term>
<term>Survival rate</term>
<term>Survivor</term>
<term>Syndrome</term>
<term>Systematic review</term>
<term>Tata</term>
<term>Tata memorial hospital</term>
<term>Temozolomide</term>
<term>Teratoma</term>
<term>Therapy</term>
<term>Toxicity</term>
<term>Transplantation</term>
<term>Treatment outcome</term>
<term>Tumor</term>
<term>Tumor growth</term>
<term>Tumori</term>
<term>Tumour</term>
<term>Univariate</term>
<term>Univariate analysis</term>
<term>University hospital</term>
<term>Vegf</term>
<term>Venous</term>
<term>Villejuif</term>
<term>Vincristine</term>
<term>Whilst</term>
<term>Wilms</term>
<term>Wilms tumor</term>
<term>Wroclaw</term>
<term>Xenograft</term>
<term>Young adults</term>
<term>Young children</term>
<term>Young people</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sarre/explor/MusicSarreV3/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000154 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000154 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sarre |area= MusicSarreV3 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:3672584BC4E06AB98E4CE39A8536380086DA16DA |texte= 44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts }}
This area was generated with Dilib version V0.6.33. |